Abstract

Objective: Gestational trophoblastic neoplasia (GTN) is a group of malignant diseases derived from trophoblastic cells with abnormal proliferation and metastasis. The FIGO 2000 staging and risk factor scoring system has been globally used for guiding management and predicting prognosis of GTN patients, but its accuracy still needs to be improved. It has been reported that exosomal molecules can be used as diagnostic and prognostic biomarkers in many types of tumors.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.